Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

VivoSim Labs, INC. Director's Dealing 2014

Dec 31, 2014

35369_dirs_2014-12-31_82bab326-122e-477f-84d3-e94158191672.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ORGANOVO HOLDINGS, INC. (ONVO)
CIK: 0001497253
Period of Report: 2014-12-29

Reporting Person: David Eric (Chief Strategy Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-12-29 Common Stock S 3700 $7.5011 Disposed 697706 Direct
2014-12-30 Common Stock S 16300 $7.5609 Disposed 681306 Direct

Footnotes

F1: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $7.50 to $7.52. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F3: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $7.50 to $7.6250. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F4: This number does not include 840,000 shares of common stock underlying outstanding options held by Mr. David; post-transaction Mr. David continues to beneficially own or have a right to acquire 1,521,306 shares of common stock.